9 Meters Biopharma (NMTR) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsTrendsBuy This Stock NMTR vs. QLGN, EVAX, SNGX, NBY, PWUP, THAR, CNSP, REVB, SPRC, and TTNPShould you be buying 9 Meters Biopharma stock or one of its competitors? The main competitors of 9 Meters Biopharma include Qualigen Therapeutics (QLGN), Evaxion A/S (EVAX), Soligenix (SNGX), NovaBay Pharmaceuticals (NBY), PowerUp Acquisition (PWUP), Tharimmune (THAR), CNS Pharmaceuticals (CNSP), Revelation Biosciences (REVB), SciSparc (SPRC), and Titan Pharmaceuticals (TTNP). These companies are all part of the "pharmaceutical products" industry. 9 Meters Biopharma vs. Its Competitors Qualigen Therapeutics Evaxion A/S Soligenix NovaBay Pharmaceuticals PowerUp Acquisition Tharimmune CNS Pharmaceuticals Revelation Biosciences SciSparc Titan Pharmaceuticals Qualigen Therapeutics (NASDAQ:QLGN) and 9 Meters Biopharma (NASDAQ:NMTR) are both small-cap medical companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, institutional ownership, profitability, dividends, analyst recommendations, risk, media sentiment and valuation. Do insiders & institutionals have more ownership in QLGN or NMTR? 3.2% of Qualigen Therapeutics shares are held by institutional investors. Comparatively, 22.3% of 9 Meters Biopharma shares are held by institutional investors. 1.8% of Qualigen Therapeutics shares are held by insiders. Comparatively, 2.4% of 9 Meters Biopharma shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Which has more volatility & risk, QLGN or NMTR? Qualigen Therapeutics has a beta of -0.17, indicating that its share price is 117% less volatile than the S&P 500. Comparatively, 9 Meters Biopharma has a beta of 1.36, indicating that its share price is 36% more volatile than the S&P 500. Does the media favor QLGN or NMTR? In the previous week, Qualigen Therapeutics' average media sentiment score of 0.00 equaled 9 Meters Biopharma'saverage media sentiment score. Company Overall Sentiment Qualigen Therapeutics Neutral 9 Meters Biopharma Neutral Which has stronger valuation & earnings, QLGN or NMTR? Qualigen Therapeutics has higher revenue and earnings than 9 Meters Biopharma. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioQualigen Therapeutics$4.98M0.60-$6.26MN/AN/A9 Meters BiopharmaN/AN/A-$43.77M-$3.46N/A Is QLGN or NMTR more profitable? Qualigen Therapeutics' return on equity of 0.00% beat 9 Meters Biopharma's return on equity.Company Net Margins Return on Equity Return on Assets Qualigen TherapeuticsN/A N/A -260.91% 9 Meters Biopharma N/A -584.97%-159.45% Summary9 Meters Biopharma beats Qualigen Therapeutics on 4 of the 7 factors compared between the two stocks. Get 9 Meters Biopharma News Delivered to You Automatically Sign up to receive the latest news and ratings for NMTR and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMTR and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMTR vs. The Competition Export to ExcelMetric9 Meters BiopharmaBiotechnology IndustryMedical SectorNASDAQ ExchangeMarket Cap$3K$137.45M$5.51B$9.72BDividend YieldN/A3.74%4.60%4.12%P/E Ratio0.003.7830.0124.75Price / SalesN/A4,424.80450.7297.72Price / CashN/A13.1936.7758.47Price / BookN/A39.278.185.59Net Income-$43.77M-$90.99M$3.26B$265.99M 9 Meters Biopharma Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMTR9 Meters BiopharmaN/AN/AN/AN/A$3KN/A0.0020Gap DownQLGNQualigen TherapeuticsN/A$2.50-10.9%N/A-82.8%$4.08MN/A0.0050Upcoming EarningsGap DownEVAXEvaxion A/S1.5004 of 5 stars$2.91-0.9%$10.00+243.2%-77.8%$4.05M$3.29M-2.4960Upcoming EarningsGap UpSNGXSoligenix2.2638 of 5 stars$1.25-2.3%$6.00+380.0%-7.6%$4.04M$120K-0.2920News CoverageGap UpNBYNovaBay Pharmaceuticals1.4539 of 5 stars$0.65+1.0%$0.85+30.8%+51.9%$3.78M$9.78M-0.0130PWUPPowerUp AcquisitionN/A$0.48-3.7%N/AN/A$3.74MN/A0.00N/AHigh Trading VolumeTHARTharimmune3.3155 of 5 stars$1.40-4.5%$17.00+1,118.6%-58.7%$3.71MN/A-0.182CNSPCNS Pharmaceuticals2.0256 of 5 stars$8.22+0.4%$300.00+3,549.6%-93.7%$3.70MN/A0.005Upcoming EarningsREVBRevelation Biosciences0.266 of 5 stars$2.40-10.8%N/A-95.0%$3.67MN/A-0.0110News CoveragePositive NewsEarnings ReportSPRCSciSparc0.5814 of 5 stars$6.81-7.0%N/A-20.3%$3.61M$1.31M0.004News CoverageTTNPTitan Pharmaceuticals0.2147 of 5 stars$3.95-9.9%N/A-35.9%$3.53M$180K-0.8410Positive NewsUpcoming EarningsHigh Trading Volume Related Companies and Tools Related Companies QLGN Alternatives EVAX Alternatives SNGX Alternatives NBY Alternatives PWUP Alternatives THAR Alternatives CNSP Alternatives REVB Alternatives SPRC Alternatives TTNP Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMTR) was last updated on 8/10/2025 by MarketBeat.com Staff From Our PartnersGENIUS Act: Cancel Your Money?A new law called the GENIUS Act could quietly trigger the most radical shift in American finance in decades. B...Priority Gold | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…Goldco Precious Metals | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredMarket Crash Warning: How to Protect Your Wealth Before August 12thChina tariffs hit August 12—and experts warn a market meltdown may follow. A free guide from American Alter...American Alternative | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredBREAKING: The House just passed 3 pro-crypto bills!THREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding 9 Meters Biopharma, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share 9 Meters Biopharma With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMTR Stock Alerts